Immuron ceo, steven lydeamore to present at bioshares

Melbourne, australia, july 24, 2023 (globe newswire) -- immuron limited (asx: imc; nasdaq: imrn), an australian based and globally integrated biopharmaceutical company is pleased to advise our chief executive officer, steven lydeamore will be presenting at the 17th bioshares biotech summit in hobart, australia on july 24th.
IMRN Ratings Summary
IMRN Quant Ranking